AMA: FDA action on OTC naloxone will save people from overdoses

| 1 Min Read

Statement attributable to:
Patrice A. Harris, MD, MA
President-elect, chair of the AMA Opioid Task Force
American Medical Association

“The AMA applauds the FDA and Commissioner Gottlieb for today’s action to provide labeling that would allow for over-the-counter availability of naloxone, a move that will save people from opioid-related overdose. Naloxone has saved tens of thousands of lives, and the AMA continues to strongly urge physicians to co-prescribe naloxone to patients at risk of opioid-related overdose.

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Physical therapist with patient

OIG reports blast prior authorization use in Medicare Advantage

| 5 Min Read
Graph showing upward trend

More utilization drives U.S. health spending to nearly $5.3 trillion

| 4 Min Read
W keys from a keyboard

3 keys to getting paid and thriving in private practice

| 6 Min Read
Patient with a hand to chest

What doctors want patients to know about heart failure

| 12 Min Read